Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Cooper

Showing results (291-300 of 324) with videos related to

Pageof 33
Sort By:
Vaccine|September 19, 2016
The primary immune response to Vaccinia virus vaccination includes cells with a distinct cytotoxic effector CD4 T-cell phenotypeC Mee Ling Munier, David van Bockel, Michelle Bailey, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 29, 2009
High levels of human antigen-specific CD4+ T cells in peripheral blood revealed by stimulated coexpression of CD25 and CD134 (OX40)John J Zaunders, Mee Ling Munier, Nabila Seddiki, et al.
The Journal of Infectious Diseases|January 11, 2013
Inhibition of telomerase activity by human immunodeficiency virus (HIV) nucleos(t)ide reverse transcriptase inhibitors: a potential factor contributing to HIV-associated accelerated agingEdwin Leeansyah, Paul U Cameron, Ajantha Solomon, et al.
The Journal of Infectious Diseases|July 20, 2005
Impact of therapeutic immunization on HIV-1 viremia after discontinuation of antiretroviral therapy initiated during acute infectionSabine Kinloch-de Loes, Bruno Hoen, Don E Smith, et al.
Journal of Virology|May 26, 2017
Anti-HIV-1 ADCC Antibodies following Latency Reversal and Treatment InterruptionWen Shi Lee, Anne B Kristensen, Thomas A Rasmussen, et al.
The New England Journal of Medicine|July 21, 2015
Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection, Jens D Lundgren, Abdel G Babiker, et al.
The Lancet. HIV|August 26, 2018
The cascade of HIV care among key populations in Indonesia: a prospective cohort studyPande Putu Januraga, Joanne Reekie, Tri Mulyani, et al.
Frontiers in Immunology|May 10, 2017
HIV-1 and SIV Predominantly Use CCR5 Expressed on a Precursor Population to Establish Infection in T Follicular Helper CellsYin Xu, Chansavath Phetsouphanh, Kazuo Suzuki, et al.
The Journal of Infectious Diseases|January 20, 2011
Sex, race, and geographic region influence clinical outcomes following primary HIV-1 infectionAmie L Meditz, Samantha MaWhinney, Amanda Allshouse, et al.
Journal of Virology|September 29, 2006
Infection of CD127+ (interleukin-7 receptor+) CD4+ cells and overexpression of CTLA-4 are linked to loss of antigen-specific CD4 T cells during primary human immunodeficiency virus type 1 infectionJohn J Zaunders, Susanna Ip, Mee Ling Munier, et al.
Pageof 33

Showing results (291-300 of 324) with videos related to

Sort By:
Pageof 33
Vaccine|September 19, 2016
The primary immune response to Vaccinia virus vaccination includes cells with a distinct cytotoxic effector CD4 T-cell phenotypeC Mee Ling Munier, David van Bockel, Michelle Bailey, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 29, 2009
High levels of human antigen-specific CD4+ T cells in peripheral blood revealed by stimulated coexpression of CD25 and CD134 (OX40)John J Zaunders, Mee Ling Munier, Nabila Seddiki, et al.
The Journal of Infectious Diseases|January 11, 2013
Inhibition of telomerase activity by human immunodeficiency virus (HIV) nucleos(t)ide reverse transcriptase inhibitors: a potential factor contributing to HIV-associated accelerated agingEdwin Leeansyah, Paul U Cameron, Ajantha Solomon, et al.
The Journal of Infectious Diseases|July 20, 2005
Impact of therapeutic immunization on HIV-1 viremia after discontinuation of antiretroviral therapy initiated during acute infectionSabine Kinloch-de Loes, Bruno Hoen, Don E Smith, et al.
Journal of Virology|May 26, 2017
Anti-HIV-1 ADCC Antibodies following Latency Reversal and Treatment InterruptionWen Shi Lee, Anne B Kristensen, Thomas A Rasmussen, et al.
The New England Journal of Medicine|July 21, 2015
Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection, Jens D Lundgren, Abdel G Babiker, et al.
The Lancet. HIV|August 26, 2018
The cascade of HIV care among key populations in Indonesia: a prospective cohort studyPande Putu Januraga, Joanne Reekie, Tri Mulyani, et al.
Frontiers in Immunology|May 10, 2017
HIV-1 and SIV Predominantly Use CCR5 Expressed on a Precursor Population to Establish Infection in T Follicular Helper CellsYin Xu, Chansavath Phetsouphanh, Kazuo Suzuki, et al.
The Journal of Infectious Diseases|January 20, 2011
Sex, race, and geographic region influence clinical outcomes following primary HIV-1 infectionAmie L Meditz, Samantha MaWhinney, Amanda Allshouse, et al.
Journal of Virology|September 29, 2006
Infection of CD127+ (interleukin-7 receptor+) CD4+ cells and overexpression of CTLA-4 are linked to loss of antigen-specific CD4 T cells during primary human immunodeficiency virus type 1 infectionJohn J Zaunders, Susanna Ip, Mee Ling Munier, et al.
Pageof 33